We have for the first time elucidated the molecular mechanism (Figure8) by which ARL5B drives lipid metabolic reprogramming and malignant progression in ESCC through regulating the ROCK1‐mediated SREBP1 activation pathway. This evidence concerns the gene ARL5B and esophageal squamous cell carcinoma.